Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569737 · ClinicalTrials.gov registry record
Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
A clinical trial, sponsored by HRA Pharma.
- Completed
- Registry status
- 98
- Enrollment target
NCT01569737 is a clinical trial that has completed, run by HRA Pharma. The registered enrollment target is 98 participants.
The verdict
NCT01569737 has completed, sponsored by HRA Pharma.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.
Interventions
- DRUG ella
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2014-11-18 |
| Est. Completion | 2018-06-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01569737
The ClinicalTrials.gov registry entry for NCT01569737 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HRA Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ella is the first listed.
NCT01569737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01569737 about?
NCT01569737 is a clinical study titled "Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella". The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.
What is the current status of trial NCT01569737?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2014-11-18. Estimated completion is 2018-06-29.
What interventions are being tested in trial NCT01569737?
The interventions under investigation include: ella (DRUG).
Who is sponsoring clinical trial NCT01569737?
This trial is sponsored by HRA Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.